The lawsuit alleges that an advertisement featuring Patanjali Ayurved founder Baba Ramdev falsely claims that only Patanjali's Chyawanprash is 'original'
Baba Ramdev-led Patanjali Ayurved's total income has risen by 23.15 per cent to Rs 9,335.32 crore in 2023-24, helped by other income which includes OFS of Patanjali Foods (earlier known as Ruchi Soya) and income from other group entities, according to RoC filing by the company. In FY24 Patanjali Ayurved's other income was at Rs 2,875.29 crore against Rs 46.18 crore in the year-ago period, according to financial data accessed through business intelligence platform Tofler. Its revenue from operations, which is mainly income from net sales, was down 14.25 per cent to Rs 6,460.03 crore for the financial year ended on March 31, 2024. Revenue was impacted as Patanjali Ayurved transferred its food business to Patanjali Foods on July 1, 2022, which includes biscuits, ghee, cereals, and nutraceuticals. It reported a five-fold jump in its total profit to Rs 2,901.10 crore in FY24. Patanjali Ayurved reported a total profit of Rs 578.44 crore on a revenue of Rs 7,533.88 crore for the financi
Ramdev's fresh statement followed two days after the Supreme Court closed contempt proceedings against Patanjali Ayurved co-founders for misleading the public through ill-informed advertisements
Patanjali misleading ads case: The lawsuit accused yoga guru Ramdev of undermining public trust in allopathic treatments and promoting misinformation during the Covid-19 pandemic
The Delhi High Court instructed Ramdev to remove the contentious content from social media within three days
The Delhi High Court will on Monday pronounce its order on a plea by several doctors' associations against Yoga guru Ramdev over his claim of 'Coronil' being a "cure" for COVID-19. The plea forms a part of a 2021 lawsuit by the doctors' associations against the Ramdev, his associate Acharya Balkrishna as well as Patanjali Ayurveda. Justice Anup Jairam Bhambhani had reserved the order on the issue on May 21 after hearing the parties. According to the lawsuit, Ramdev made "unsubstantiated claims" with respect to 'Coronil' being a cure for COVID-19, contrary to the licence granted to the drug for merely being an "immuno-booster". The senior counsel appearing for the doctors had sought a direction to restrain the defendants, Ramdev and others, from making further similar statements. Three Resident Doctors' Association of the All India Institute of Medical Sciences at Rishikesh, Patna and Bhubaneswar as well as Association of Resident Doctors, Post Graduate Institute of Medical Educati
The court had initially restrained Patanjali from selling its camphor products on August 30, 2023
The Bombay High Court has directed Patanjali Ayurved to deposit Rs 50 lakh for alleged breach of the HC's interim order restraining it from selling its camphor products, in relation to a trademark infringement case filed by another company. Following trademark infringement allegations by Mangalam Organics Ltd, the HC in an interim order in August 2023 restrained Patanjali Ayurved Ltd from selling its camphor products. A single bench of Justice R I Chagla on July 8 noted that Patanjali, in an affidavit submitted in June, admitted breach of the earlier order granting injunction against sale of the impugned camphor products. "Such persistent breach of the injunction order dated 30th August 2023 by defendant no. 1 (Patanjali) cannot be tolerated by this court," Justice Chagla said in the order, a copy of which was made available on Wednesday. The bench said it would be appropriate to direct Patanjali to deposit a sum of Rs 50 lakh prior to passing of an order for contempt/breach of the
Patanjali tells Supreme Court it has stopped selling 14 products whose manufacturing licences were suspended in Uttarakhand
A case in this regard was registered in 2021 after reports found the samples did not meet the food safety standards
The District Food Safety Officer of Pithoragarh collected the 'soan papdi' from a shop in Berinag Market in September 2019 following concerns about the Patanjali product
The court is hearing a petition filed by the Indian Medical Association (IMA) against Patanjali's advertisements attacking allopathy and making claims about curing certain diseases
Indian Medical Association (IMA) president R V Asokan on Tuesday tendered an unconditional apology to the Supreme Court and expressed regret for his statement against the apex court in an interview to PTI where he answered queries about Patanjali Ayurved Ltd's misleading advertisements case. The matter came up for hearing before a bench of justices Hima Kohli and Ahsanuddin Amanullah which posed some tough questions to Asokan and made it clear that at this stage, the apex court will not accept his affidavit tendering unconditional apology. In an affidavit filed in the top court, Asokan said he has realised his error that he ought not have made such statements in the interview when the matter was under consideration of the court. "The deponent (Asokan) hereby tenders his unconditional apology and expresses regret for his statements in relation to the order dated April 23, 2024 passed by this court in the present writ petition," the affidavit said. In its April 23 order, the apex cou
IMA President Dr RV Asokan drew sharp criticism from the Supreme Court for his remarks concerning the court's ruling in a case involving misleading advertisements by Patanjali Ayurved
Balkrishna and Patanjali Ayurved also served notice in Patanjali misleading ads case
It is imperative for celebrities and public figures to act responsibly while endorsing a consumer product, the Supreme Court said on Tuesday as it clamped down on misleading advertisements. The apex court directed that before an advertisement is permitted to be issued, a self-declaration be obtained from advertisers on the line of the Cable Television Network Rules, 1994. Rule 7 of the 1994 law stipulates an advertisement code that says advertisements carried should be designed to be conformity with the laws of the country. A bench of Justices Hima Kohli and Ahsanuddin Amanullah also directed the Union ministries concerned to apprise it of misleading advertisements and the action taken or proposed to be taken against them by the Central Consumer Protection Authority (CCPA). "Endorsements by celebrities, influencers and public figures go a long way in promoting products and it is imperative for them to act with responsibility while endorsing any product in the course of advertisemen
The Supreme Court on Tuesday termed as "very, very unacceptable" the statements made by Indian Medical Association (IMA) president R V Asokan targeting the apex court in a recent interview where he answered questions about Patanjali Ayurved's misleading advertisements case. Expressing displeasure over Asokan's comments a day before the top court was slated to the hear the matter, a bench of Justices Hima Kohli and Ahsanuddin Amanullah sought his response on an application filed by Patanjali Ayurved Ltd. Senior advocate Mukul Rohatgi, appearing for Patanjali, told the bench that they have filed an application urging the court to take judicial notice of the "wanton and unwarranted comments" made by the IMA president. "This is a very serious issue. They are trying to divert the course of justice Your lordships asked one or two queries and see how they are reacting as if nobody can ask anything," Rohatgi said. Rohatgi said at the last hearing, he had handed over to the court the ...
The Supreme Court on Tuesday appreciated the "marked improvement" in the unconditional public apology published in newspapers by yoga guru Ramdev, his aide Balkrishna and Patanjali Ayurved Ltd in the misleading advertisements case. A bench of justices Hima Kohli and Ahsanuddin Amanullah told senior advocate Mukul Rohatgi, appearing for Ramdev, Balkrishna and Patanjali Ayurved Ltd, that language of the apology was adequate and the names were also there in it. "I don't know the second apology is on whose vetting. There has been marked improvement," Justice Amanullah said, adding, "We appreciate that. Now finally they have understood." He said earlier when the apology was published, only the company's name was there. "Now the names have come. It is a marked improvement, we appreciate that," Justice Amanullah observed, adding, "The language is adequate." During the hearing, the apex court asked the firm's counsel as to why they have e-filed the apology published in newspapers when the
In the latest advertisement, Ramdev and his associate Balkrishna expressed their sincere apologies
The Supreme Court had earlier questioned the size and visibility of Patanjali Ayurved's earlier apology concerning misleading advertisements